This is an archive of past discussions. Do not edit the contents of this page. If you wish to start a new discussion or revive an old one, please do so on the current talk page. |
Archive 1 | Archive 2 | Archive 3 |
This is a Wikipedia
user talk page. This is not an encyclopedia article or the talk page for an encyclopedia article. If you find this page on any site other than Wikipedia, you are viewing a mirror site. Be aware that the page may be outdated and that the user in whose space this page is located may have no personal affiliation with any site other than Wikipedia. The original talk page is located at https://en.wikipedia.org/wiki/User_talk:Garrondo/Archive_1. |
Hello, Garrondo/Archive 1, and
welcome to Wikipedia. Thank you for
your contributions. I hope you like the place and decide to stay. If you are stuck, and looking for help, please come to the
New contributors' help page, where experienced Wikipedians can answer any queries you have! Or, you can just type {{helpme}}
and your question on your user talk page, and someone will show up shortly to answer. Here are a few good links for newcomers:
We hope you enjoy editing here and being a Wikipedian! By the way, you can sign your name on talk and vote pages using four tildes, like this: ~~~~. If you have any questions, see the help pages, add a question to the village pump or ask me on my talk page. Again, welcome! -- Ginkgo100 talk 22:56, 8 March 2007 (UTC)
Edward Bower 01:32, 9 March 2007 (UTC)
Thanks for uploading Image:Types of MS-2.jpg. Wikipedia gets thousands of images uploaded every day, and in order to verify that the images can be legally used on Wikipedia, the source and copyright status must be indicated. Images need to have an image tag applied to the image description page indicating the copyright status of the image. This uniform and easy-to-understand method of indicating the license status allows potential re-users of the images to know what they are allowed to do with the images.
For more information on using images, see the following pages:
This is an automated notice by OrphanBot. If you need help on selecting a tag to use, or in adding the tag to the image description, feel free to post a message at Wikipedia:Media copyright questions. 18:14, 18 April 2007 (UTC)
I redid my warning. It is needed especially in view of misleading information about long-term efficacy of disease modifying treatments. Laetoli ( talk) 16:15, 10 April 2008 (UTC)
Creo que la localización es tan específica como en cualquiera de los otros síntomas y en todo caso su única diferencia es que sus efectos son ´más visibles que otros. Incluso en el mismo artículo habla de donde deben darse las lesiones para que ocurran: En el caso de la neuritis la inflamación debe comprimir el nervio optico, en el caso de la oftalmoplegia en el tronco cerebral y en el caso de la mielitis en la médula..., por lo que no me parece válida tu razón para mantenerlos de manera tan preponderante en el artículo en comparación con el resto de síntomas.
Bien hecho. La página de pathophsyiology realmente necesitaba un empujón.
Una pregunta ¿Era Luccinetti o Luchinetti? Aparece 2 veces el nombre y cada una de las 2 es distinto.
Por mi parte estoy creando un template para tratar de poner en contacto las diferentes páginas sobre MS y crear una especie de proyecto sobre MS ya que creo que a día de hoy la página general está francamente bien. Cuando lo tenga hecho te lo enseño.
He puesto en la pagina de discusión de multiple sclerosis el template que he creado; a ver que te parece.
Luego corregiré lo de Lucchinetti si no lo has corregido tu... La verdad es que todos andamos muy mal de tiempo... pero poco a poco esto va para adelante. El template pensaba ponerlo además del que está y también en las páginas a las que señala directamente relacionadas con la página central. Yo ahora voy a intentar ir mejorando el artículo de los síntomas, ya que el de patofisiología se me escapa un poco, pero iré poco a poco. De la enfermedad de Schilder yo también encontré muy poco...pero por lo menos con lo que puse ya da una idea. Quedaba feo el link sin información. Bueno... un saludo que a mi ahora me toca trabajar con EM en directo. -- Garrondo 07:32, 7 May 2007 (UTC)
No creo que el lugar en el template del EAE sea en borderline forms al ser un modelo animal. Personalmente creo que sería mejor ponerlo en algún tipo de categoría tipo investigación. Te parece?-- Garrondo 13:40, 8 May 2007 (UTC)
Seguro que el nombre correcto es Schilder's disease, porque el que puso Schilder en las páginas de MS fuí yo, y lo saqué de un artículo francés (y los franceses hablan el inglés todavia peor que yo) Ya me encargo yo de la fusión. Si te parece me cargo todo menos los nombres de las enfermedades raras. Parece que el que escribió eso sabía lo que estaba diciendo. —The preceding unsigned comment was added by Juansempere ( talk • contribs) 16:27, 8 May 2007 (UTC).
Hola Gonzalo,
Por lo que he visto en varios artículos, la forma mas extendida de denominar a estas enfermedades es IIDDs (idiopathic inflammatory demyelinating diseases). Si te parece bien, le cambio el título al artículo.
Can you please help me to cite Phineas Gage? I don't really know a lot about him, but I can help out with formatting a bit. The main things that'll need citing are page numbers for any direct quotes, and citations (w page numbers) for anything unusual. I can't find any study by Raveena on Google Scholar - could you please find the source for that? - Malkinann 06:10, 2 June 2007 (UTC)
Rather than putting the <ref> tag just as is, the first time you use the reference, you put <ref name="Catchy name goes here"> and then go on to put in the reference: Blow, J. (2027) On citing references more than once in Wikipedia, Journal of Wikipedia, 3(1) pp. 27-56 and you finish off the ref tags with </ref>. So you end up with: <ref name="Catchy name goes here">Blow, J. (2027) On citing references more than once in Wikipedia, Journal of Wikipedia, 3(1) pp. 27-56</ref>. The second time you want to use the reference, you copy and paste the "<ref name =" bit and put a / in it. as in <ref name="Catchy name goes here"/>. the only way this stuffs up is if the first reference is removed, or if the catchy name is changed. You can find out more about citing the same reference more than once at WP:FOOT. Hope this helps. - Malkinann 22:38, 5 June 2007 (UTC)
¿Qué tal Gonzalo? No he podido evitar buscarte en Wikipedia después de que esta mañana comentaras en la comida del laboratorio que sueles colaborar por aquí. A mi también me gusta escribir de vez en cuando algún artículo, pero de momento sólo en castellano. Un saludo, Iñigo.
Hi, there. In case you didn't know, when you add content to talk pages and Wikipedia pages that have open discussion, you should sign your posts by typing four tildes ( ~~~~ ) at the end of your comment. On many keyboards, the tilde is entered by holding the Shift key, and pressing the key with the tilde pictured. You may also click on the signature button located above the edit window. This will automatically insert a signature with your name and the time you posted the comment. This information is useful because other editors will be able to tell who said what, and when. Thank you! -- SineBot 16:05, 1 September 2007 (UTC)
You have added Therapies for multiple sclerosis to WP:SPR but you have not told us what you want from the review. You should have created Wikipedia:Scientific peer review/Therapies for multiple sclerosis with a comment. I have created it with a header, but it needs a comment from you. -- Bduke 02:31, 2 September 2007 (UTC)
You're welcome. You've done so much work on it, and you certainly deserve congratulations; with this kind of dedication, the article's surely headed for good things and better ones :) Best, Fvasconcellos ( t· c) 15:03, 2 September 2007 (UTC)
Pues el verano me ha ido bien. He estado de viaje por Italia. Siempre alegra ver que se acuerdan de uno al volver. Saludos, Juan —Preceding unsigned comment added by Juansempere ( talk • contribs) 21:04, 6 September 2007 (UTC)
I agree the page is very specialist, and I am not very qualified in assessing whether the article is complete. When faced with this conundrum, I personally prefer to get an expert on board who can externally peer review the article (as has happened on coeliac disease).
Perhaps somewhat more emphasis should be placed on professional guidelines. In the UK we have a clinical practice guideline from NICE ( CG8) that should probably be quoted together with other notable guidelines. JFW | T@lk 15:45, 10 September 2007 (UTC)
You have undone my text: "No therapy has yet been proved to delay conversion from relapsing-remitting to secondary progressive multiple sclerosis." It is usual pratice for the burden of proof to lie with people advocating treatments. What I say is true and yet, of course it is hard to proove a negative. Rather than delete my text please provide a citation showing a treatment that delays onset of SPMS.
You have also removed my text on psysiotherapy - this is perhaps the only treatment which has been shown to make a difference in the longer term.
You have also undone my text (based on needing a better citation): "Some have argued [C. Confavreux of EDMUS in ECTRIMS 2007] that inflammation may cause relapses but that neuro-degeneration causes disability[2], in which case treatments that reduce inflammation may have no effect on long-term disease course (as has been amply demonstated in the case of steroids)". What Confavreux says is becoming more genrallty understood. Why do you disagree? What is wrong with my citation?
It is important to be especially rigourous when addressing pharmaceutical treatments, particularly because large sums of money are involved. I feel the article is rather buying down the pharma line AND no citations are given for named treatment regimes.
I am copying this text in MS talk. Laetoli ( talk) —Preceding comment was added at 12:44, 24 November 2007 (UTC)
You've obviously put a great deal of work into the articles on MS. When I recently found a personal reason (not, in the end, MS) to read them I was terribly impressed by their even-handedness and scope. They gave me a lot of information that was scattered elsewhere on the internet, sometimes full of complicated medical-ese and sometimes of dubious reliability. The articles here were informative, well-sourced and addressed controversies and disagreements in a terrifically NPOV way. You've done great work and should be proud. Dina 17:20, 19 October 2007 (UTC)
Hi, Garrondo. I don't have time to give the article the attention it deserves right now, but I'll have a look as soon as possible. Best, Fvasconcellos ( t· c) 14:35, 25 October 2007 (UTC)
Hi again, I am afraid that I don't have too much knowledge about wikipedia. How can I vote for a featured article? -- Juansempere 12:54, 27 October 2007 (UTC)
While my comments on the value of these articles still stand, I got all editor-ish and have been making some changes. Only language tweaking, to relieve what I perceive to be a little stiffness. Let me know what you think. I think this is a great FA candidate. Dina 01:14, 29 October 2007 (UTC)
I have seen your fantastico work on MS and wanted to see if you could read through the Alzheimer's disease page and give some comments on what looks good and what is unclear. We are working toward shortening it and may move toward a Therapies in Alzheimer's disease page like you have done with MS. muchisimas gracias -- Chrispounds 14:57, 1 November 2007 (UTC)
Please see my comments at Talk:Dietary treatments for multiple sclerosis. I am proposing deletion of the article as it is prone to abuse and the information is already covered or can be covered elsewhere. Let's discuss if you object. OccamzRazor 03:16, 8 November 2007 (UTC)
Don't worry, it can be quite a while. It's been about 12 days since the Featured article director ( Raul) promoted/archived, so it shouldn't be much longer :) Fvasconcellos ( t· c) 16:23, 17 November 2007 (UTC)
{{featured article}}to the very bottom of the page. Again, congratulations—keep up the good work :) Best, Fvasconcellos ( t· c) 12:49, 19 November 2007 (UTC)
I wasn't clear in my edit summary, but if a national organisation adopts an awareness ribbon - as for multiple sclerosis - I think that merits inclusion into the article. I've left a message on Talk:Multiple sclerosis to this effect. JFW | T@lk 10:06, 21 November 2007 (UTC)
Laetoli has removed most of his comments on Talk:Multiple sclerosis and left a message on my talkpage indicating that he will not be editing anymore. He has, however, left a piece of text for consideration on the talkpage with regards to the side-effects of pulsed MP, plasmapheresis etc, with a few references. I was wondering what you thought about this.
Laetoli seems to indicate that while treatment for RRMS may give short-term benefit, but does not delay secondary progression. If this is not borne out sufficiently by the article, perhaps we should have a look into this. JFW | T@lk 20:46, 27 November 2007 (UTC)
I have just moved your page, Multiple Sclerosis organizations, to List of multiple sclerosis organizations and updated the other places it could be found. The move is solely motivated by making the article title match the normal pattern, and a redirect is in place for the old name. As you're the creator, I wanted to make sure that you knew where your page is now. WhatamIdoing ( talk) 20:13, 27 November 2007 (UTC)
Just a note to register my admiration for your hard work on our MS-related content. I'm sorry you've been rather alone on your quest to get the treatment approved for FA, but I think that reflects the paucity of neurology expertise on the project rather than apathy. It seems we have a new contributor with an interest in neurology, Sanjpatel1 ( talk · contribs). If you're stuck he may be able to help. JFW | T@lk 20:16, 4 December 2007 (UTC)
As someone with a partner who has Spanish as a first language, I have a pretty good appreciation of the challenges of writing in another language--especially when the language is a horrible one like ingles. I am glad to help out by polishing the gems you have added to the piece. You have added a lot to the article, but I am not going to take the time to read the source articles written in castellano y francais to validate your points. We have a great article now, and we continue to make it even better. -- Chrispounds ( talk) 14:51, 14 January 2008 (UTC)
You'll kick yourself with IMO - it just means 'in my opinion' (I use it quite a lot!) -- Matt Lewis ( talk) 00:04, 20 January 2008 (UTC)
Garrondo since your in the field i wanted you to take a look at the talk page for Cognitive Retention Therapy i just added a link to Grandparent magazine i would like you to read and let me know how i can fit that into the article. Thanks -- Chris Ashby | Talk 18:56, 30 January 2008 (UTC)
An editor has nominated Alzheimer's in the media, an article on which you have worked or that you created, for deletion. We appreciate your contributions, but the nominator doesn't believe that the article satisfies Wikipedia's criteria for inclusion and has explained why in his/her nomination (see also " What Wikipedia is not").
Your opinions on whether the article meets inclusion criteria and what should be done with the article are welcome; please participate in the discussion by adding your comments at Wikipedia:Articles for deletion/Alzheimer's in the media and please be sure to sign your comments with four tildes (~~~~).
You may also edit the article during the discussion to improve it but should not remove the articles for deletion template from the top of the article; such removal will not end the deletion debate. Thank you. BJBot ( talk) 09:44, 22 January 2008 (UTC)
It's been a while since I last looked at Alzheimer's disease. I then noticed it on WP:GA, and thought: "How on earth?" Then I noticed that you'd been at it. Absolutely brilliant. Keep up the good work. Have a barnstar:
Hi Garrondo, I have not heard back from you since we had a brief discussion on the Treatments for MS page. I wanted to talk to further about this, as you have provided the largest contribution to date. Here is another example of the same issue we were addressing - http://www.thisisms.com/article101.html - despite having fooled the MS Community here with it's "remarkable efficacy", it does not stand up to close examination. In fact, it is worse than unethical in using the unfortunate "treatment-failure" patients in order to imply a favourable comparison. Do you agree, or disagree ?
In any case my goal is to make a relative-efficacy table, and I wonder if we can collaborate on this. I can offer to dig up references/citations. io-io ( talk) 18:02, 6 February 2008 (UTC)
ps: After posting here, I found this - http://www.thisisms.com/ftopict-5018.html - in case you think that MS-ers are not easily fooled. That is why I think painting an accurate picture is important. Greetings, io-io ( talk) 18:08, 6 February 2008 (UTC)
Hi, noticed your revision on the page this morning - I was following the classifications on the main MS page, and which includes PRMS...has world body decided it is really a form of SPMS ?......tx..... io-io ( talk) 16:40, 10 March 2008 (UTC)
Thanks for the prompt input. I think we're already at the point where the article will withstand any AFD that should arise. LeadSongDog ( talk) 20:03, 18 February 2008 (UTC)
Thanks so much for the star you gave me for the article reading. Yes, it was quite a bit of work, so it's very nice to know that it's appreciated. Cheers, Leo. Leotohill ( talk) 17:47, 8 March 2008 (UTC)
Thanks for that - it really does apply here perfectly to the PML profile :o) :o) :o) ....anyway, made you 3 replies because I had missed earlier comments (and there is some talk that page may be improved....your input on Wiki is appreciated here) - will come back to ALZ later.... io-io ( talk) 03:44, 17 March 2008 (UTC)
I was hoping to send you an email, but it seems you have deactivated the feature. If you don't want to activate this now, could you send me a message and I will reply to you. JFW | T@lk 22:30, 22 March 2008 (UTC)
Dear Garrondo, I apologise unreservedly for any offence that I may have caused you. It was not my intention to make personal attacks - I realise that I sometimes act in a hot-headed manner when I get upset about things. Take care, Paul Laetoli ( talk) 14:18, 16 April 2008 (UTC)
I just stalked your user page. DId you know that User:Jfdwolff and JWF are the same editor? Your user page is redundant!
Also, were you aware of the ISBN search tool, diberri and the google ref generator? They're all ridiculously handy (especially Diberri). WLU ( talk) 17:44, 18 April 2008 (UTC)
This drug has been shown to reduce number of attacks & their severity. However, since RRMS is characterised only by attacks/relapses with no steady decline during the periods in between, then it follows that it only reduces severity of attacks and not disease severity (except on temporary MSSS scale during & following relapse) which can easily be confused with delaying onset of SPMS (which it has not been shown to do). Laetoli ( talk) 13:24, 24 April 2008 (UTC)
Can we add Lyme Disease as a form of subcortical dementia? Given the number of cases globally and the potential for misdiagnosis, this seems reasonable. —Preceding unsigned comment added by Damwiki1 ( talk • contribs) 19:51, 24 May 2008 (UTC)
Hi Garrondo. I really appreciate all the work you've done on this article, and you should be commended. However, please don't be offended because I'll be doing some copyediting to your grammar and style. Together we can get this article to FA, I hope!!!! OrangeMarlin Talk• Contributions 14:16, 18 June 2008 (UTC)
The E=mc² Barnstar | ||
For outstanding service to cleaning up, improving, and rewriting Alzheimer's disease OrangeMarlin Talk• Contributions 14:47, 18 June 2008 (UTC) |
Hi,
I need your help. I am working on a research project at Boston College, studying creation of medical information on Wikipedia. You are being contacted, because you have been identified as an important contributor to one or more articles.
Would you will be willing to answer a few questions about your experience? We've done considerable background research, but we would also like to gather the insight of the actual editors. Details about the project can be found at the user page of the project leader,
geraldckane. Survey questions can be found at
geraldckane/medsurvey. Your privacy and confidentiality will be strictly protected!
The questions should only take a few minutes. I hope you will be willing to complete the survey, as we do value your insight. Please do not hesitate to contact me or Professor Kane if you have any questions.
Thank You, Sam4bc ( talk) 15:05, 15 July 2008 (UTC)
When you emailed, did you replace "_@_" with "@" in the address? (Just checking... ;/) LeadSongDog ( talk) 18:30, 29 July 2008 (UTC)
Nice to know somebody read it! Tim Vickers ( talk) 00:07, 1 August 2008 (UTC)
Hi there! Sure, I'll help. I'm having a lot of Internet trouble today, but I'll see what I can do. Best, Fvasconcellos ( t· c) 15:35, 13 August 2008 (UTC)
I think we're close to getting this finished up. Sorry that I misunderstood "both" in the recent drug trials. I know English isn't your first language, so it was a minor grammatical difference that confused me! Anyways, I think you did a great job getting this here. What's next? :) OrangeMarlin Talk• Contributions 17:01, 20 August 2008 (UTC)
Congratulations on getting AD featured. I'm sorry I never got around to commenting at FAC—I did some copy editing, but then I saw significant changes being made to the article and decided to wait until it was more stable. Sorry about that, and congratulations again! Fvasconcellos ( t· c) 15:17, 2 September 2008 (UTC)
I usually take a little break from complex editing after a big effort that I had with Alzheimer's disease and Helicobacter pylori. I'm not very good with neurological diseases, I'm just good at copyediting and digging up references. So, as long as you know MS quite well, including all of that biochemical stuff, I can help out!!! I'm ready to get energetic with another article, but MS looks like it doesn't require an FAR or anything major. OrangeMarlin Talk• Contributions 14:28, 15 September 2008 (UTC)
Thank you very much, Garrondo, for your comments at peer review! Real life has, as they say, gotten in the way yesterday and today. I'll comment at that page as soon as I can, and I'll let you know when I've done so. Thanks again! -- Hordaland ( talk) 11:51, 18 September 2008 (UTC)
Sounds like a good idea to me. I have no experience with merging WikiProjects though, there's a lot of work to do to merge talk pages etc. — Cyclonenim ( talk · contribs · email) 10:23, 17 October 2008 (UTC)
Hi,
seems like we had some kind of edit conflict there :-) but I seemed to have beaten you :-p.
I've undid you, just copy-edit if you disagree.
cheers, -- Steven Fruitsmaak ( Reply) 18:42, 23 October 2008 (UTC)
This page is an archive of past discussions. Do not edit the contents of this page. If you wish to start a new discussion or revive an old one, please do so on the current talk page. |
This is an archive of past discussions. Do not edit the contents of this page. If you wish to start a new discussion or revive an old one, please do so on the current talk page. |
Archive 1 | Archive 2 | Archive 3 |
This is a Wikipedia
user talk page. This is not an encyclopedia article or the talk page for an encyclopedia article. If you find this page on any site other than Wikipedia, you are viewing a mirror site. Be aware that the page may be outdated and that the user in whose space this page is located may have no personal affiliation with any site other than Wikipedia. The original talk page is located at https://en.wikipedia.org/wiki/User_talk:Garrondo/Archive_1. |
Hello, Garrondo/Archive 1, and
welcome to Wikipedia. Thank you for
your contributions. I hope you like the place and decide to stay. If you are stuck, and looking for help, please come to the
New contributors' help page, where experienced Wikipedians can answer any queries you have! Or, you can just type {{helpme}}
and your question on your user talk page, and someone will show up shortly to answer. Here are a few good links for newcomers:
We hope you enjoy editing here and being a Wikipedian! By the way, you can sign your name on talk and vote pages using four tildes, like this: ~~~~. If you have any questions, see the help pages, add a question to the village pump or ask me on my talk page. Again, welcome! -- Ginkgo100 talk 22:56, 8 March 2007 (UTC)
Edward Bower 01:32, 9 March 2007 (UTC)
Thanks for uploading Image:Types of MS-2.jpg. Wikipedia gets thousands of images uploaded every day, and in order to verify that the images can be legally used on Wikipedia, the source and copyright status must be indicated. Images need to have an image tag applied to the image description page indicating the copyright status of the image. This uniform and easy-to-understand method of indicating the license status allows potential re-users of the images to know what they are allowed to do with the images.
For more information on using images, see the following pages:
This is an automated notice by OrphanBot. If you need help on selecting a tag to use, or in adding the tag to the image description, feel free to post a message at Wikipedia:Media copyright questions. 18:14, 18 April 2007 (UTC)
I redid my warning. It is needed especially in view of misleading information about long-term efficacy of disease modifying treatments. Laetoli ( talk) 16:15, 10 April 2008 (UTC)
Creo que la localización es tan específica como en cualquiera de los otros síntomas y en todo caso su única diferencia es que sus efectos son ´más visibles que otros. Incluso en el mismo artículo habla de donde deben darse las lesiones para que ocurran: En el caso de la neuritis la inflamación debe comprimir el nervio optico, en el caso de la oftalmoplegia en el tronco cerebral y en el caso de la mielitis en la médula..., por lo que no me parece válida tu razón para mantenerlos de manera tan preponderante en el artículo en comparación con el resto de síntomas.
Bien hecho. La página de pathophsyiology realmente necesitaba un empujón.
Una pregunta ¿Era Luccinetti o Luchinetti? Aparece 2 veces el nombre y cada una de las 2 es distinto.
Por mi parte estoy creando un template para tratar de poner en contacto las diferentes páginas sobre MS y crear una especie de proyecto sobre MS ya que creo que a día de hoy la página general está francamente bien. Cuando lo tenga hecho te lo enseño.
He puesto en la pagina de discusión de multiple sclerosis el template que he creado; a ver que te parece.
Luego corregiré lo de Lucchinetti si no lo has corregido tu... La verdad es que todos andamos muy mal de tiempo... pero poco a poco esto va para adelante. El template pensaba ponerlo además del que está y también en las páginas a las que señala directamente relacionadas con la página central. Yo ahora voy a intentar ir mejorando el artículo de los síntomas, ya que el de patofisiología se me escapa un poco, pero iré poco a poco. De la enfermedad de Schilder yo también encontré muy poco...pero por lo menos con lo que puse ya da una idea. Quedaba feo el link sin información. Bueno... un saludo que a mi ahora me toca trabajar con EM en directo. -- Garrondo 07:32, 7 May 2007 (UTC)
No creo que el lugar en el template del EAE sea en borderline forms al ser un modelo animal. Personalmente creo que sería mejor ponerlo en algún tipo de categoría tipo investigación. Te parece?-- Garrondo 13:40, 8 May 2007 (UTC)
Seguro que el nombre correcto es Schilder's disease, porque el que puso Schilder en las páginas de MS fuí yo, y lo saqué de un artículo francés (y los franceses hablan el inglés todavia peor que yo) Ya me encargo yo de la fusión. Si te parece me cargo todo menos los nombres de las enfermedades raras. Parece que el que escribió eso sabía lo que estaba diciendo. —The preceding unsigned comment was added by Juansempere ( talk • contribs) 16:27, 8 May 2007 (UTC).
Hola Gonzalo,
Por lo que he visto en varios artículos, la forma mas extendida de denominar a estas enfermedades es IIDDs (idiopathic inflammatory demyelinating diseases). Si te parece bien, le cambio el título al artículo.
Can you please help me to cite Phineas Gage? I don't really know a lot about him, but I can help out with formatting a bit. The main things that'll need citing are page numbers for any direct quotes, and citations (w page numbers) for anything unusual. I can't find any study by Raveena on Google Scholar - could you please find the source for that? - Malkinann 06:10, 2 June 2007 (UTC)
Rather than putting the <ref> tag just as is, the first time you use the reference, you put <ref name="Catchy name goes here"> and then go on to put in the reference: Blow, J. (2027) On citing references more than once in Wikipedia, Journal of Wikipedia, 3(1) pp. 27-56 and you finish off the ref tags with </ref>. So you end up with: <ref name="Catchy name goes here">Blow, J. (2027) On citing references more than once in Wikipedia, Journal of Wikipedia, 3(1) pp. 27-56</ref>. The second time you want to use the reference, you copy and paste the "<ref name =" bit and put a / in it. as in <ref name="Catchy name goes here"/>. the only way this stuffs up is if the first reference is removed, or if the catchy name is changed. You can find out more about citing the same reference more than once at WP:FOOT. Hope this helps. - Malkinann 22:38, 5 June 2007 (UTC)
¿Qué tal Gonzalo? No he podido evitar buscarte en Wikipedia después de que esta mañana comentaras en la comida del laboratorio que sueles colaborar por aquí. A mi también me gusta escribir de vez en cuando algún artículo, pero de momento sólo en castellano. Un saludo, Iñigo.
Hi, there. In case you didn't know, when you add content to talk pages and Wikipedia pages that have open discussion, you should sign your posts by typing four tildes ( ~~~~ ) at the end of your comment. On many keyboards, the tilde is entered by holding the Shift key, and pressing the key with the tilde pictured. You may also click on the signature button located above the edit window. This will automatically insert a signature with your name and the time you posted the comment. This information is useful because other editors will be able to tell who said what, and when. Thank you! -- SineBot 16:05, 1 September 2007 (UTC)
You have added Therapies for multiple sclerosis to WP:SPR but you have not told us what you want from the review. You should have created Wikipedia:Scientific peer review/Therapies for multiple sclerosis with a comment. I have created it with a header, but it needs a comment from you. -- Bduke 02:31, 2 September 2007 (UTC)
You're welcome. You've done so much work on it, and you certainly deserve congratulations; with this kind of dedication, the article's surely headed for good things and better ones :) Best, Fvasconcellos ( t· c) 15:03, 2 September 2007 (UTC)
Pues el verano me ha ido bien. He estado de viaje por Italia. Siempre alegra ver que se acuerdan de uno al volver. Saludos, Juan —Preceding unsigned comment added by Juansempere ( talk • contribs) 21:04, 6 September 2007 (UTC)
I agree the page is very specialist, and I am not very qualified in assessing whether the article is complete. When faced with this conundrum, I personally prefer to get an expert on board who can externally peer review the article (as has happened on coeliac disease).
Perhaps somewhat more emphasis should be placed on professional guidelines. In the UK we have a clinical practice guideline from NICE ( CG8) that should probably be quoted together with other notable guidelines. JFW | T@lk 15:45, 10 September 2007 (UTC)
You have undone my text: "No therapy has yet been proved to delay conversion from relapsing-remitting to secondary progressive multiple sclerosis." It is usual pratice for the burden of proof to lie with people advocating treatments. What I say is true and yet, of course it is hard to proove a negative. Rather than delete my text please provide a citation showing a treatment that delays onset of SPMS.
You have also removed my text on psysiotherapy - this is perhaps the only treatment which has been shown to make a difference in the longer term.
You have also undone my text (based on needing a better citation): "Some have argued [C. Confavreux of EDMUS in ECTRIMS 2007] that inflammation may cause relapses but that neuro-degeneration causes disability[2], in which case treatments that reduce inflammation may have no effect on long-term disease course (as has been amply demonstated in the case of steroids)". What Confavreux says is becoming more genrallty understood. Why do you disagree? What is wrong with my citation?
It is important to be especially rigourous when addressing pharmaceutical treatments, particularly because large sums of money are involved. I feel the article is rather buying down the pharma line AND no citations are given for named treatment regimes.
I am copying this text in MS talk. Laetoli ( talk) —Preceding comment was added at 12:44, 24 November 2007 (UTC)
You've obviously put a great deal of work into the articles on MS. When I recently found a personal reason (not, in the end, MS) to read them I was terribly impressed by their even-handedness and scope. They gave me a lot of information that was scattered elsewhere on the internet, sometimes full of complicated medical-ese and sometimes of dubious reliability. The articles here were informative, well-sourced and addressed controversies and disagreements in a terrifically NPOV way. You've done great work and should be proud. Dina 17:20, 19 October 2007 (UTC)
Hi, Garrondo. I don't have time to give the article the attention it deserves right now, but I'll have a look as soon as possible. Best, Fvasconcellos ( t· c) 14:35, 25 October 2007 (UTC)
Hi again, I am afraid that I don't have too much knowledge about wikipedia. How can I vote for a featured article? -- Juansempere 12:54, 27 October 2007 (UTC)
While my comments on the value of these articles still stand, I got all editor-ish and have been making some changes. Only language tweaking, to relieve what I perceive to be a little stiffness. Let me know what you think. I think this is a great FA candidate. Dina 01:14, 29 October 2007 (UTC)
I have seen your fantastico work on MS and wanted to see if you could read through the Alzheimer's disease page and give some comments on what looks good and what is unclear. We are working toward shortening it and may move toward a Therapies in Alzheimer's disease page like you have done with MS. muchisimas gracias -- Chrispounds 14:57, 1 November 2007 (UTC)
Please see my comments at Talk:Dietary treatments for multiple sclerosis. I am proposing deletion of the article as it is prone to abuse and the information is already covered or can be covered elsewhere. Let's discuss if you object. OccamzRazor 03:16, 8 November 2007 (UTC)
Don't worry, it can be quite a while. It's been about 12 days since the Featured article director ( Raul) promoted/archived, so it shouldn't be much longer :) Fvasconcellos ( t· c) 16:23, 17 November 2007 (UTC)
{{featured article}}to the very bottom of the page. Again, congratulations—keep up the good work :) Best, Fvasconcellos ( t· c) 12:49, 19 November 2007 (UTC)
I wasn't clear in my edit summary, but if a national organisation adopts an awareness ribbon - as for multiple sclerosis - I think that merits inclusion into the article. I've left a message on Talk:Multiple sclerosis to this effect. JFW | T@lk 10:06, 21 November 2007 (UTC)
Laetoli has removed most of his comments on Talk:Multiple sclerosis and left a message on my talkpage indicating that he will not be editing anymore. He has, however, left a piece of text for consideration on the talkpage with regards to the side-effects of pulsed MP, plasmapheresis etc, with a few references. I was wondering what you thought about this.
Laetoli seems to indicate that while treatment for RRMS may give short-term benefit, but does not delay secondary progression. If this is not borne out sufficiently by the article, perhaps we should have a look into this. JFW | T@lk 20:46, 27 November 2007 (UTC)
I have just moved your page, Multiple Sclerosis organizations, to List of multiple sclerosis organizations and updated the other places it could be found. The move is solely motivated by making the article title match the normal pattern, and a redirect is in place for the old name. As you're the creator, I wanted to make sure that you knew where your page is now. WhatamIdoing ( talk) 20:13, 27 November 2007 (UTC)
Just a note to register my admiration for your hard work on our MS-related content. I'm sorry you've been rather alone on your quest to get the treatment approved for FA, but I think that reflects the paucity of neurology expertise on the project rather than apathy. It seems we have a new contributor with an interest in neurology, Sanjpatel1 ( talk · contribs). If you're stuck he may be able to help. JFW | T@lk 20:16, 4 December 2007 (UTC)
As someone with a partner who has Spanish as a first language, I have a pretty good appreciation of the challenges of writing in another language--especially when the language is a horrible one like ingles. I am glad to help out by polishing the gems you have added to the piece. You have added a lot to the article, but I am not going to take the time to read the source articles written in castellano y francais to validate your points. We have a great article now, and we continue to make it even better. -- Chrispounds ( talk) 14:51, 14 January 2008 (UTC)
You'll kick yourself with IMO - it just means 'in my opinion' (I use it quite a lot!) -- Matt Lewis ( talk) 00:04, 20 January 2008 (UTC)
Garrondo since your in the field i wanted you to take a look at the talk page for Cognitive Retention Therapy i just added a link to Grandparent magazine i would like you to read and let me know how i can fit that into the article. Thanks -- Chris Ashby | Talk 18:56, 30 January 2008 (UTC)
An editor has nominated Alzheimer's in the media, an article on which you have worked or that you created, for deletion. We appreciate your contributions, but the nominator doesn't believe that the article satisfies Wikipedia's criteria for inclusion and has explained why in his/her nomination (see also " What Wikipedia is not").
Your opinions on whether the article meets inclusion criteria and what should be done with the article are welcome; please participate in the discussion by adding your comments at Wikipedia:Articles for deletion/Alzheimer's in the media and please be sure to sign your comments with four tildes (~~~~).
You may also edit the article during the discussion to improve it but should not remove the articles for deletion template from the top of the article; such removal will not end the deletion debate. Thank you. BJBot ( talk) 09:44, 22 January 2008 (UTC)
It's been a while since I last looked at Alzheimer's disease. I then noticed it on WP:GA, and thought: "How on earth?" Then I noticed that you'd been at it. Absolutely brilliant. Keep up the good work. Have a barnstar:
Hi Garrondo, I have not heard back from you since we had a brief discussion on the Treatments for MS page. I wanted to talk to further about this, as you have provided the largest contribution to date. Here is another example of the same issue we were addressing - http://www.thisisms.com/article101.html - despite having fooled the MS Community here with it's "remarkable efficacy", it does not stand up to close examination. In fact, it is worse than unethical in using the unfortunate "treatment-failure" patients in order to imply a favourable comparison. Do you agree, or disagree ?
In any case my goal is to make a relative-efficacy table, and I wonder if we can collaborate on this. I can offer to dig up references/citations. io-io ( talk) 18:02, 6 February 2008 (UTC)
ps: After posting here, I found this - http://www.thisisms.com/ftopict-5018.html - in case you think that MS-ers are not easily fooled. That is why I think painting an accurate picture is important. Greetings, io-io ( talk) 18:08, 6 February 2008 (UTC)
Hi, noticed your revision on the page this morning - I was following the classifications on the main MS page, and which includes PRMS...has world body decided it is really a form of SPMS ?......tx..... io-io ( talk) 16:40, 10 March 2008 (UTC)
Thanks for the prompt input. I think we're already at the point where the article will withstand any AFD that should arise. LeadSongDog ( talk) 20:03, 18 February 2008 (UTC)
Thanks so much for the star you gave me for the article reading. Yes, it was quite a bit of work, so it's very nice to know that it's appreciated. Cheers, Leo. Leotohill ( talk) 17:47, 8 March 2008 (UTC)
Thanks for that - it really does apply here perfectly to the PML profile :o) :o) :o) ....anyway, made you 3 replies because I had missed earlier comments (and there is some talk that page may be improved....your input on Wiki is appreciated here) - will come back to ALZ later.... io-io ( talk) 03:44, 17 March 2008 (UTC)
I was hoping to send you an email, but it seems you have deactivated the feature. If you don't want to activate this now, could you send me a message and I will reply to you. JFW | T@lk 22:30, 22 March 2008 (UTC)
Dear Garrondo, I apologise unreservedly for any offence that I may have caused you. It was not my intention to make personal attacks - I realise that I sometimes act in a hot-headed manner when I get upset about things. Take care, Paul Laetoli ( talk) 14:18, 16 April 2008 (UTC)
I just stalked your user page. DId you know that User:Jfdwolff and JWF are the same editor? Your user page is redundant!
Also, were you aware of the ISBN search tool, diberri and the google ref generator? They're all ridiculously handy (especially Diberri). WLU ( talk) 17:44, 18 April 2008 (UTC)
This drug has been shown to reduce number of attacks & their severity. However, since RRMS is characterised only by attacks/relapses with no steady decline during the periods in between, then it follows that it only reduces severity of attacks and not disease severity (except on temporary MSSS scale during & following relapse) which can easily be confused with delaying onset of SPMS (which it has not been shown to do). Laetoli ( talk) 13:24, 24 April 2008 (UTC)
Can we add Lyme Disease as a form of subcortical dementia? Given the number of cases globally and the potential for misdiagnosis, this seems reasonable. —Preceding unsigned comment added by Damwiki1 ( talk • contribs) 19:51, 24 May 2008 (UTC)
Hi Garrondo. I really appreciate all the work you've done on this article, and you should be commended. However, please don't be offended because I'll be doing some copyediting to your grammar and style. Together we can get this article to FA, I hope!!!! OrangeMarlin Talk• Contributions 14:16, 18 June 2008 (UTC)
The E=mc² Barnstar | ||
For outstanding service to cleaning up, improving, and rewriting Alzheimer's disease OrangeMarlin Talk• Contributions 14:47, 18 June 2008 (UTC) |
Hi,
I need your help. I am working on a research project at Boston College, studying creation of medical information on Wikipedia. You are being contacted, because you have been identified as an important contributor to one or more articles.
Would you will be willing to answer a few questions about your experience? We've done considerable background research, but we would also like to gather the insight of the actual editors. Details about the project can be found at the user page of the project leader,
geraldckane. Survey questions can be found at
geraldckane/medsurvey. Your privacy and confidentiality will be strictly protected!
The questions should only take a few minutes. I hope you will be willing to complete the survey, as we do value your insight. Please do not hesitate to contact me or Professor Kane if you have any questions.
Thank You, Sam4bc ( talk) 15:05, 15 July 2008 (UTC)
When you emailed, did you replace "_@_" with "@" in the address? (Just checking... ;/) LeadSongDog ( talk) 18:30, 29 July 2008 (UTC)
Nice to know somebody read it! Tim Vickers ( talk) 00:07, 1 August 2008 (UTC)
Hi there! Sure, I'll help. I'm having a lot of Internet trouble today, but I'll see what I can do. Best, Fvasconcellos ( t· c) 15:35, 13 August 2008 (UTC)
I think we're close to getting this finished up. Sorry that I misunderstood "both" in the recent drug trials. I know English isn't your first language, so it was a minor grammatical difference that confused me! Anyways, I think you did a great job getting this here. What's next? :) OrangeMarlin Talk• Contributions 17:01, 20 August 2008 (UTC)
Congratulations on getting AD featured. I'm sorry I never got around to commenting at FAC—I did some copy editing, but then I saw significant changes being made to the article and decided to wait until it was more stable. Sorry about that, and congratulations again! Fvasconcellos ( t· c) 15:17, 2 September 2008 (UTC)
I usually take a little break from complex editing after a big effort that I had with Alzheimer's disease and Helicobacter pylori. I'm not very good with neurological diseases, I'm just good at copyediting and digging up references. So, as long as you know MS quite well, including all of that biochemical stuff, I can help out!!! I'm ready to get energetic with another article, but MS looks like it doesn't require an FAR or anything major. OrangeMarlin Talk• Contributions 14:28, 15 September 2008 (UTC)
Thank you very much, Garrondo, for your comments at peer review! Real life has, as they say, gotten in the way yesterday and today. I'll comment at that page as soon as I can, and I'll let you know when I've done so. Thanks again! -- Hordaland ( talk) 11:51, 18 September 2008 (UTC)
Sounds like a good idea to me. I have no experience with merging WikiProjects though, there's a lot of work to do to merge talk pages etc. — Cyclonenim ( talk · contribs · email) 10:23, 17 October 2008 (UTC)
Hi,
seems like we had some kind of edit conflict there :-) but I seemed to have beaten you :-p.
I've undid you, just copy-edit if you disagree.
cheers, -- Steven Fruitsmaak ( Reply) 18:42, 23 October 2008 (UTC)
This page is an archive of past discussions. Do not edit the contents of this page. If you wish to start a new discussion or revive an old one, please do so on the current talk page. |